Нови АТЦ кодове през 2021
| ATC code | ATC level name |
|---|---|
| A03AX15 | menthae piperitae aetheroleum |
| A05BA09 | metadoxine |
| A06AX08 | tenapanor |
| A10BD26 | metformin and lobeglitazone |
| A10BG04 | lobeglitazone |
| A10BH08 | teneligliptin |
| A10BJ07 | beinaglutide |
| A10BK07 | luseogliflozin |
| A16AX16 | givosiran |
| A16AX17 | triheptanoin |
| A16AX18 | lumasiran |
| A16AX30 | sodium benzoate and sodium phenylacetate |
| B03AD05 | ferrous gluconate |
| B05XA18 | zinc sulfate |
| B06AX02 | betibeglogene autotemcel |
| C01DX22 | vericiguat |
| C09BX05 | ramipril and bisoprolol |
| C10AX16 | inclisiran |
| C10BA10 | bempedoic acid and ezetimibe |
| C10BX18 | atorvastatin, amlodipine and ramipril |
| D01BA03 | fosravuconazole |
| D05AX55 | tazarotene and ulobetasol |
| D06BX03 | tirbanibulin |
| D10AF07 | minocycline |
| D11AH07 | tralokinumab |
| D11AX26 | caffeine |
| G02CX05 | bremelanotide |
| G03AA18 | drospirenone and estetrol |
| H01AC07 | somapacitan |
| H01CC54 | relugolix, estradiol and norethisterone |
| H02CA03 | ketoconazole |
| H05AA04 | abaloparatide |
| H05BX05 | calcifediol |
| J01DH56 | imipenem, cilastatin and relebactam |
| J01DI04 | cefiderocol |
| J01MA24 | levonadifloxacin |
| J01MA25 | lascufloxacin |
| J04AK08 | pretomanid |
| J05AJ04 | cabotegravir |
| J05AX28 | bulevirtide |
| J05AX29 | fostemsavir |
| J07BB04 | influenza, virus like particles |
| J07BX02 | ebola vaccines |
| L01EE04 | selumetinib |
| L01EH03 | tucatinib |
| L01EL03 | zanubrutinib |
| L01EM04 | duvelisib |
| L01EX15 | pexidartinib |
| L01EX16 | erdafitinib |
| L01EX17 | capmatinib |
| L01EX18 | avapritinib |
| L01EX19 | ripretinib |
| L01EX20 | pemigatinib |
| L01EX21 | tepotinib |
| L01XC34 | moxetumomab pasudotox |
| L01XC35 | tafasitamab |
| L01XC36 | enfortumab vedotin |
| L01XC37 | polatuzumab vedotin |
| L01XC38 | isatuximab |
| L01XC39 | belantamab mafodotin |
| L01XC40 | dostarlimab |
| L01XC41 | trastuzumab deruxtecan |
| L01XK05 | veliparib |
| L01XX69 | lurbinectedin |
| L01XX70 | axicabtagene ciloleucel |
| L01XX71 | tisagenlecleucel |
| L01XY02 | pertuzumab and trastuzumab |
| L04AA45 | filgotinib |
| L04AA46 | itacitinib |
| L04AA47 | inebilizumab |
| L04AC19 | satralizumab |
| M02AA29 | esflurbiprofen |
| M09AX08 | golodirsen |
| M09AX09 | onasemnogene abeparvovec |
| M09AX10 | risdiplam |
| M09AX11 | palovarotene |
| N01BB59 | bupivacaine and meloxicam |
| N02AA11 | oxymorphone |
| N02BG11 | mirogabalin |
| N03AX25 | cenobamate |
| N03AX26 | fenfluramine |
| N04CX01 | istradefyllin |
| N05CD15 | nimetazepam |
| R01AD59 | mometasone, combinations |
| R07AX32 | ivacaftor, tezacaftor and elexacaftor |
| S01GA07 | brimonidine |
| S01LA07 | abicipar pegol |
Нови АТЦ кодове трето и четвърто ниво
| ATC code | ATC 3rd and 4th level name |
|---|---|
| J05AJ | Integrase inhibitors |
| L01CE | Topoisomerase 1 (TOP1) inhibitors |
| L01E | PROTEIN KINASE INHIBITORS |
| L01EA | BCR-ABL tyrosine kinase inhibitors |
| L01EB | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors |
| L01EC | B-Raf serine-threonine kinase (BRAF) inhibitors |
| L01ED | Anaplastic lymphoma kinase (ALK) inhibitors |
| L01EE | Mitogen-activated protein kinase (MEK) inhibitors |
| L01EF | Cyclin-dependent kinase (CDK) inhibitors |
| L01EG | Mammalian target of rapamycin (mTOR) kinase inhibitors |
| L01EH | Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors |
| L01EJ | Janus-associated kinase (JAK) inhibitors |
| L01EK | Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors |
| L01EL | Bruton’s tyrosine kinase (BTK) inhibitors |
| L01EM | Phosphatidylinositol-3-kinase (Pi3K) inhibitors |
| L01EX | Other protein kinase inhibitors |
| L01XF | Retinoids for cancer treatment |
| L01XG | Proteasome inhibitors |
| L01XH | Histone deacetylase (HDAC) inhibitors |
| L01XJ | Hedgehog pathway inhibitors |
| L01XK | Poly (ADP-ribose) polymerase (PARP) inhibitors |
| N04C | OTHER ANTIPARKINSON DRUGS |
| N04CX | Other antiparkinson drugs |
Последна актуализация на сайта на СЗО: 14-12-2020 г.